Paper7019707
Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.
Freidenberg GR and 5 others. N Engl J Med, 1981. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin. Papers, record 7019707. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7019707
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus | Major topic |
| Infusions, Parenteral | Major topic |
| Insulin | Major topic |
| Staphylococcal Protein A | Major topic |
| Adolescent | |
| Adult | |
| Blood Glucose | |
| Diabetes Mellitus, Type 1 | |
| Drug Combinations | |
| Female | |
| Humans | |
| Injections, Intramuscular | |
| Injections, Subcutaneous |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GCRC-NIH | PHS HHS | United States | PubMed | |
| RR-00036 | NCRR NIH HHS | United States | PubMed | |
| RR-34 | NCRR NIH HHS | United States | PubMed |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41472947 | Exogenous Insulin Antibody Syndrome and Subsequent Severe Subcutaneous Insulin Resistance Complicating Type 1 Diabetes. | JCEM Case Rep | 2026 | https://conductscience.org/library/papers/41472947 | PubMed |
| 34765736 | A Rare Case of Subcutaneous Insulin Resistance Presumed to be due to Paraneoplastic Process in Pancreatic Adenocarcinoma. | AACE Clin Case Rep | 2021 | https://conductscience.org/library/papers/34765736 | PubMed |
| 31967031 | USE OF INHALED INSULIN IN A PATIENT WITH SUBCUTANEOUS INSULIN RESISTANCE SYNDROME: A RARE CONDITION. | AACE Clin Case Rep | 2019 | https://conductscience.org/library/papers/31967031 | PubMed |
| 30603298 | A case of local delayed-type allergy to zinc-containing insulin as a cause of diabetic ketoacidosis in a patient with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion. | Diabetol Int | 2016 | https://conductscience.org/library/papers/30603298 | PubMed |
| 29682315 | Insulin therapy for type 2 diabetes - are we there yet? The d-Nav® story. | Clin Diabetes Endocrinol | 2018 | https://conductscience.org/library/papers/29682315 | PubMed |
| 6797511 | Brittle diabetes: long-term control with a portable, continuous, intravenous insulin infusion system. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6797511 | PubMed |
| 6634559 | Unrecognised nocturnal hypoglycaemia masquerading as senile dementia. | Postgrad Med J | 1983 | https://conductscience.org/library/papers/6634559 | PubMed |
| 6386586 | Low subcutaneous degradation and slow absorption of insulin in insulin-dependent diabetic patients during continuous subcutaneous insulin infusion at basal rate. | Diabetologia | 1984 | https://conductscience.org/library/papers/6386586 | PubMed |
| 6188643 | Subcutaneous aprotinin causes local hyperaemia. A possible mechanism by which aprotinin improves control in some diabetic patients. | Diabetologia | 1983 | https://conductscience.org/library/papers/6188643 | PubMed |
| 6176491 | Subcutaneous degradation of insulin. | Diabetologia | 1982 | https://conductscience.org/library/papers/6176491 | PubMed |
| 4054447 | Brittle diabetes--present concepts. | Diabetologia | 1985 | https://conductscience.org/library/papers/4054447 | PubMed |
| 4037902 | Implantable infusion pump management of insulin resistant diabetes mellitus. | Ann Surg | 1985 | https://conductscience.org/library/papers/4037902 | PubMed |
| 3641509 | Relevance of plasma, glandular and urinary kallikrein in renal hypertrophy in streptozotocin-diabetic rats. | Acta Diabetol Lat | 1986 | https://conductscience.org/library/papers/3641509 | PubMed |
| 2429615 | Alphavirus replication in cultured cells and infected animals is inhibited by antiproteinase agents. | Antiviral Res | 1986 | https://conductscience.org/library/papers/2429615 | PubMed |
| 2424018 | Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/2424018 | PubMed |
| 2415419 | Influence of aprotinin on insulin absorption and subcutaneous blood flow in type 1 (insulin-dependent) diabetes. | Diabetologia | 1985 | https://conductscience.org/library/papers/2415419 | PubMed |
| 1901649 | Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors. | Pharm Res | 1991 | https://conductscience.org/library/papers/1901649 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7019707
GET https://conductscience.org/api/papers/v1/7019707/authors